I was just diagnosed with COVID-19. Is Monoclonal Antibody Treatment an option for me?
Monoclonal antibody treatment is a promising therapeutic for people diagnosed with mild to moderate COVID-19. The FDA has issued Emergency Use Authorization (EUA) for this treatment for patients who meet certain high-risk criteria.
If you are diagnosed with COVID-19, please reach out to your provider to see if you are a candidate for this promising treatment designed to reduce symptoms, and/or symptom progression. Find a location near your current assignment location.
Monoclonal Antibody treatment is at no charge to the patient. Centers are opening across the country but are in the infancy stage. Your assignment facility may even be one of the locations offering this treatment. FEMA is also involved in staffing Monoclonal Antibody Treatment Centers in some of the high need areas of the country.